To date, only 3 publications have reported on the administration of BPC 157 to humans
Journal of Physiology-Paris 87:313327 Sikiric P, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH (2018) Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157
& Brady, D
N, Suite B, Berea KY 40403 We use cookies to analyze website traffic and optimize your website experience
Long-term use of this medicine may lead to an increased risk of side effects
Expired or improperly stored MOTS-c loses its three-dimensional peptide structure through denaturation, rendering it inactiveit wont bind to AMPK receptors effectively, meaning youre injecting an inert solution with no metabolic benefit